15th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from Orlando

Denver, CO US
February 12, 2026

The 15th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from Orlando provides an invaluable educational experience highlighting the latest advances in malignant and non-malignant hematology. Please join us and engage with experts to learn and gain practical insights on current therapies, and innovative treatments. Available on-demand, this activity ensures that health care professionals caring for these patients have unlimited access to the latest scientific updates, innovative ideas, and pressing issues in their field. Participants can gain valuable insights ultimately improving the care and outcomes of patients with hematologic malignancies.

Target Audience

The intended audience is medical oncologists, hematologists and advanced practice providers.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Incorporate emerging therapies and clinical trial data into individualized treatment plans.
  • Improve diagnostic accuracy and timeliness using updated criteria and biomarker-driven approaches.
  • Collaborate effectively across disciplines to deliver coordinated, patient-centered care.
  • Address disparities in access and outcomes through informed, equitable practices.
  • Optimize quality of life and functional outcomes for patients with complex hematologic diseases.
Course summary
Available credit: 
  • 3.00 AMA PRA Category 1 Credit™
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 3.00 Attendance
Course opens: 
12/09/2025
Course expires: 
12/31/2026
Event starts: 
02/12/2026 - 5:30pm MST
Event ends: 
02/12/2026 - 9:30pm MST
Add to calendar: 
Rating: 
0

Thursday, February 12, 2026 |5:30 – 9:30 PM (MST)
Empower Field at Mile High | Denver, CO

Date

SCHEDULEEVENT/TOPICSPEAKER(S)
5:30 - 5:35 PMWelcome & IntroductionJeffrey V. Matous, MD
Colorado Blood Cancer Institute
5:35-6:15 PMIndolent LymphomaPaolo Strati, MD
MD Anderson
6:15-6:55 PMAggressive LymphomaJavier Munoz, MD
Mayo Clinic
6:55-7:05 PMBreak 
7:05-7:45 PMMyeloid NeoplasmsHetty Carraway, MD
Cleveland Clinic
7:15-8:25 PMMultiple Myeloma and Plasma CellHans Lee, MD
Sarah Cannon Research Institute
Empower Field at Mile High
1701 Bryant St
Denver, CO 80204
United States
https://www.empowerfieldatmilehigh.com/contact

Parking: Lots A & B

Stadium Entrance: Enter through Gate 7

Coat check will be available

Course Faculty

 
Portrait of Casey Gregory

Casey Gregory

Planner

Colorado Blood Cancer Institute, Presbyterian St. Luke’s Medical Center

Portrait of Jeffrey Matous, MD

Jeffrey Matous, MD

Course Director

Colorado Blood Cancer Institute, Presbyterian St. Luke’s Medical Center

 
 

 

 

 

 
 

 

 
Course Director(s)

Jeffrey Matous, MD

has a financial relationship (Professional Services) with Janssen Pharmacyclic's;.
has a financial relationship (Professional Services) with BeiGene;.
Co-Director(s)

Peter Forsberg

has no relevant financial relationships to disclose at this time.
Planner(s)

Casey Gregory

has no relevant financial relationships to disclose at this time.
Speaker(s)

Paolo Strati, Associate Professor, MD

has a financial relationship (Grant Or Contract) with Kite/Gilead, Novartis, ADC Therapeutics/Sobi, Lilly, Incyte, Astrazeneca/Acerta, BeOne, Ipsen, Roche/Genentech, Genmab/Abbvie, ALX Oncology;.

Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation: The HCA Healthcare Continental Division designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence all parties involved in content are required to disclose all conflicts of interest with ACCME defined ineligible companies. None of the planners, faculty, and those in control of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

American Board of Internal Medicine (ABIM) 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

 

Available Credit

  • 3.00 AMA PRA Category 1 Credit™
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 3.00 Attendance
Please login or register to take this course.

Activity Registration Requirements

Learners must have a CME.HealthONEcares.com account in order to access/complete the following requirements. To complete the activity, attendees must...

  1. Participate in the activity
  2. Mark their attendance via SMS code
  3. Complete the Activity Evaluation

Learners who complete the requirements above will receive the designated credits they are eligible for. Learners interested in CME credit must verify their profession is listed in their profile in order to be eligible for credits.

Required Hardware/software

We recommend the following hardware/software to successfully view and complete the contents of this course:

For ease of use, we strongly recommend using a desktop computer to complete this course. The following desktop web browsers are compatible with our system:

Desktop: Chrome, Internet Explorer, MS Edge, Safari

While not recommended, if you are familiar with completing courses online you may complete this course using a mobile device. For those wishing to complete this activity on Mobile, the following systems are recommended:

Apple iPhones and iPad devices on iOS 10 or later
Android phones and tablets on Android OS 4.4 or later using the supported web browsers listed above.

If you encounter any issues while accessing our courses, please contact [email protected]